Navellier & Associates’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-6,423
Closed -$314K 279
2016
Q4
$314K Sell
6,423
-156
-2% -$7.63K 0.05% 219
2016
Q3
$315K Buy
+6,579
New +$315K 0.05% 202
2014
Q3
Sell
-13,364
Closed -$619K 325
2014
Q2
$619K Buy
+13,364
New +$619K 0.03% 158